Company Genetic Signatures Limited
Equities
GSS
AU000000GSS4
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 AUD | -.--% | -.--% | +67.82% |
May. 27 | Genetic Signatures Ceases Development of EasyScreen Essentials Respiratory Product for US Market; Shares Down 11% | MT |
Apr. 30 | Genetic Signatures Appoints Interim CEO | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Reagents and Consumables
97.4
%
| 34 | 96.1 % | 16 | 97.4 % | -51.53% |
Equipment Sales and Rental
2.6
%
| 1 | 3.3 % | 0 | 2.6 % | -61.88% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
82.5
%
| 28 | 79.4 % | 14 | 82.5 % | -50.30% |
EMEA
9.4
%
| 4 | 10.8 % | 2 | 9.4 % | -58.62% |
Asia Pacific
8.2
%
| 3 | 9.8 % | 1 | 8.2 % | -60.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Karl Pechmann
DFI | Director of Finance/CFO | - | 23-06-25 |
Douglas Millar
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-14 |
Michael Aicher
BRD | Director/Board Member | 64 | 14-01-01 |
Neralie Coulston
LAW | General Counsel | - | 01-12-31 |
Jackson Jones
PRN | Corporate Officer/Principal | - | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Radford
BRD | Director/Board Member | - | 15-09-14 |
Caroline Waldron
BRD | Director/Board Member | - | 22-05-12 |
Michael Aicher
BRD | Director/Board Member | 64 | 14-01-01 |
Nicholas Samaras
CHM | Chairman | - | 07-12-31 |
Director/Board Member | - | Dec. 03 | |
Neil Gunn
CEO | Chief Executive Officer | 63 | 21-04-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 186,482,642 | 134,456,857 ( 72.10 %) | 0 | 72.10 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.82% | 90.41M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.37% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- GSS Stock
- Company Genetic Signatures Limited